Covance has begun helping companies certify the accuracy and consistency of their mobile clinical trial devices and apps. The service is designed to guide companies through the process of selecting the mobile tools that will enable them to gather clinical trial data. "Covance has the expertise and scale to help our partners evaluate which apps and devices will be most effective," CEO Deborah Keller said in a statement. Release | FierceCRO